Multiplex Single-Nucleotide Primer Extension Analysis to Simultaneously Detect Eleven BRCA1 Mutations in Breast Cancer Families

Clinical Chemistry

Volumn 50, Issue 1, 2004, Pages 203-206

  Révillion, Françoise ^a   Verdière, Alain ^a   Fournier, Joëlle ^a   Hornez, Louis ^a   Peyrat, Jean Philippe ^a  

^a CENTRE OSCAR LAMBRET   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; BREAST CANCER; DIAGNOSTIC ACCURACY; DNA DETERMINATION; DNA EXTRACTION; EXON; FEMALE; GENE MUTATION; HUMAN; MULTIPLEX SINGLE NUCLEOTIDE PRIMER EXTENSION ANALYSIS; ONCOGENE; OVARY CANCER; SINGLE NUCLEOTIDE POLYMORPHISM;

BRCA1 PROTEIN; BREAST NEOPLASMS; DNA PRIMERS; FAMILY; FEMALE; HUMANS; MUTATION; POLYMERASE CHAIN REACTION;

EID: 1642492773     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2003.023713     Document Type: Article

References (10)

1. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
2. Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, et al. A collaborative survey of mutations in the BRCA1 breast and ovarian cancer susceptibility gene. JAMA 1995;273:535-41.
3. Breast Cancer Information Core. http://www.nhgri.nih.gov/Intramural_ research/Lab_transfer/Bic/ (Accessed January 2003).
4. Stoppa-Lyonnet D, Laurent-Puig P, Essioux L, Pages S, Ithier G, Ligot L, et al. BRCA1 sequence variations in 160 individuals referred to a breast/ ovarian family cancer clinic. Institut Curie Breast Cancer Group. Am J Hum Genet 1997;60:1021-30.
5. Presneau N, Laplace-Marieze V, Sylvain V, Hardouin A, Bernard-Gallon D, Bignon YJ. New mechanism of BRCA-1 mutation by deletion/insertion at the same nucleotide position In three unrelated French breast/ ovarian cancer families. Hum Genet 1998;103:334-9.
6. Peelen T, van Vliet M, Petrij-Bosch A, Mieremet R, Szabo C, van den Ouweland A, et al. A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgium hereditary breast and ovarian cancer families. Am J Human Genet 1997;60:1041-9.
7. Verhoog LC, van der Ouweland AMW, Berns E, van Veghel-Plandsoen MM, van Staveren IL, Wagner A, et al. Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families. Eur J Cancer 2001;37:2082-90.
8. Peyrat JP, Vennin P, Hornez L, Fournier J, Adenis C, Bonneterre J. Germline BRCA1 mutations In patients from 84 families with breast and/or ovarian cancers in northern France. Eur J Cancer Prev 1998;7:S7-12.
9. Fricker JP, Muller D, Cutuli B, Rodier JF, Janser JC, Jung GM, et al. Germ-line mutations of the BRCA1 gene In northeastern France. Bull Cancer 2000;87:739-44.
10. Krone N, Braun A, Weinert S, Peter M, Roscher AA, Partsch CJ, et al. Multiplex minisequencing of the 21-hydroxylase gene as a rapid strategy to confirm congenital adrenal hyperplasia. Clin Chem 2002;48:818-25.